Last reviewed · How we verify
Pharmacokinetics of certolizumab pegol
Pharmacokinetics of certolizumab pegol is a Small molecule drug developed by UCB Biopharma SRL. It is currently in Phase 1 development. Also known as: PK.
At a glance
| Generic name | Pharmacokinetics of certolizumab pegol |
|---|---|
| Also known as | PK |
| Sponsor | UCB Biopharma SRL |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis (PHASE3)
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty (PHASE2)
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- Pediatric Arthritis Study of Certolizumab Pegol (PHASE3)
- A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) (PHASE1)
- A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis (PHASE1)
- A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease (PHASE3)
- "Drugs in Lactation" Analysis Consortium
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pharmacokinetics of certolizumab pegol CI brief — competitive landscape report
- Pharmacokinetics of certolizumab pegol updates RSS · CI watch RSS
- UCB Biopharma SRL portfolio CI
Frequently asked questions about Pharmacokinetics of certolizumab pegol
What is Pharmacokinetics of certolizumab pegol?
Pharmacokinetics of certolizumab pegol is a Small molecule drug developed by UCB Biopharma SRL.
Who makes Pharmacokinetics of certolizumab pegol?
Pharmacokinetics of certolizumab pegol is developed by UCB Biopharma SRL (see full UCB Biopharma SRL pipeline at /company/ucb-biopharma-srl).
Is Pharmacokinetics of certolizumab pegol also known as anything else?
Pharmacokinetics of certolizumab pegol is also known as PK.
What development phase is Pharmacokinetics of certolizumab pegol in?
Pharmacokinetics of certolizumab pegol is in Phase 1.
Related
- Manufacturer: UCB Biopharma SRL — full pipeline
- Also known as: PK
- Compare: Pharmacokinetics of certolizumab pegol vs similar drugs
- Pricing: Pharmacokinetics of certolizumab pegol cost, discount & access